Award recordCONTRACT

PFIZER INC

PIID VA26018J2262· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $241,970 net obligations· UEI MHBQULRMEEJ5· NY

Description

SOMAVERT 15MG VIAL

First action · last action
2017-10-01 · 2019-04-15
Transactions
3
First transaction's obligation
$141,968
Base + all options value (sum of deltas)
$241,970
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P15A0001
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$241,996$0Base award · 2017-10-01 · this action $141,968 · running total $141,968Modification P00001 · 2018-05-15 · this action $100,029 · running total $241,996Modification P00002 · 2019-04-15 · this action -$27 · running total $241,970
  • Base2017-10-01+$141,968= $141,968
  • Mod P000012018-05-15+$100,029= $241,996
  • Mod P000022019-04-15-$27= $241,970
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-10-01+$141,968$141,968SOMAVERT 15MG VIAL
Mod P00001· FUNDING ONLY ACTION2018-05-15+$100,029$241,996SOMAVERT 15MG VIAL
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2019-04-15−$27$241,970SOMAVERT 15MG VIAL

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI MHBQULRMEEJ5)

AwardOffice · PSC / listingNet obligationsFY
36E79725D0032NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36E79725D0030NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36C77024P0393NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$243,101FY2024
36F79724D0130NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C25024F0047250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$215,205FY2024
36E79723A0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26018J2262_3600_VA797P15A0001_3600 · retrieved 2026-09-26.